CHEYENNE, WY / ACCESSWIRE / February 24, 2021 / MJ Biotech, Inc. (OTC PINK:MJTV), is pleased to report that Sterile and individually wrapped FDA approved nasopharyngeal (nasal) specimen collection ...
Philadelphia, June 10, 2021 - The collection of nasopharyngeal swab (NPS) samples for COVID-19 diagnostic testing poses challenges including exposure risk to healthcare workers and supply chain ...
OMAHA, Neb.--(BUSINESS WIRE)--University Medical Devices (UMD), a cutting-edge healthcare technology developer, today announced the launch of its first specimen collection method, MicroWash. Developed ...
The gold standard for the diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently based on detection using quantitative reverse-transcription polymerase chain reaction ...
The collection process for saliva and anterior nasal specimens is less invasive than the deep nasal, or nasopharyngeal, swab. In addition, both specimen types can be self-collected, reducing the risk ...
MJ Biotech announced that Sterile and individually wrapped US Food and Drug Administration (FDA) approved nasopharyngeal (nasal) specimen collection swabs for the RT-PCR Covid test was added to the ...
The combined technologies could reduce labor and time required for COVID-19 diagnostic testing 10-fold, and facilitate future diagnostic testing of other respiratory diseases. BOSTON--(BUSINESS WIRE)- ...
The collection of nasopharyngeal swab (NPS) samples for COVID-19 diagnostic testing poses challenges including exposure risk to healthcare workers and supply chain constraints. Saliva samples are ...
The addition of a simple processing step to saliva samples before testing may improve COVID-19 detection rate, eliminate the challenges of nasopharyngeal testing, and facilitate mass surveillance, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results